Christopher S. Wilcox, M.D., Ph.D. (Chairman)
• Chief, Division of Nephrology and Hypertension and Professor of Medicine at Georgetown University Medical Center.

Charles Grudzinskas, Ph.D.
• Led development programs that resulted in FDA approval of seven NDAs, including Pipracil® and Celebrex®.

Barbara J. Leibowitz, M.D.
• A practicing cardiologist who has worked in research and business development capacities at Pfizer and American Home Products (Wyeth).

David R. Savello, Ph.D.
• Senior Vice President of Development at Xenoport, Inc. who previously served as an Executive Vice President and Chief Scientific Officer for the Pharmaceutical Technologies and Services Division of Cardinal Health.

Steven H. Bloom, R.Ph.
• Vice President, Business Development at Ziopharm Oncology, Inc. who previously served as Global Vice President at Parexel and as Prozac® Brand Leader at Eli Lilly.